Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Clinical trial NCT02948426 · TERMINATED
Trial details
- NCT number
- NCT02948426
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2020-09-29
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.